METHOD OF PREVENTING GENITALIA PROLAPSE IN WOMEN OF REPRODUCTIVE PERIOD Russian patent published in 2011 - IPC A61K31/375 A61K31/565 A61K31/573 A61K33/06 A61P15/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to gynecology and can be used for prevention of genitalia prolapse in women of reproductive period. For this purpose exercises strengthening muscles of pelvic floor are done. In patient content of C-end telopeptides is determined, hormonal status is analysed, for which purpose content of estradiole, free testosterone, 170Hprogesterone is determined in first phase of menstrual cycle. If level of free testosterone is normal, level of estradiole is normal or lower, content of 170Hprogesterone is higher, patients, who are not planning pregnancy, are administered Diane-35 or Jeanine in accordance with contraceptive scheme for six months. Patients, who are planning pregnancy, are administered dexamethasone daily in the evening for three months. If content of 170Hprogesterone is 3.1 - 4.4 nmol/l, daily dose of dexamethasone equals 0.125 mg, if content of 170Hprogesterone is 4.5-7.0 nmol/l - 0.25 mg of dexamethasone, if content of 170Hprogesterone is higher than 7.0 nmol/l - 0.5 mg of dexamethasone; if content of C-end telopeptides is higher than 0.6 ng/ml additionally administered is ascorbic acid in dose 500 mg 3 times per day, magnerot in dose 500 mg 3 times per day for three months.

EFFECT: method ensures increase of efficiency of prevention of genitalia prolapse due to differentiated approach depending on hormonal status state and collagen metabolism in women of reproductive period by normalisation of hormonal status and correction of collagen-forming processes.

5 ex